Treatment of inflammatory bowel disease using oral dosage...

Details Treatment of inflammatory bowel disease using oral dosage... Treatment of inflammatory bowel disease using oral dosage...

A - Human Necessities

61

K

A61K 31/20 (2006.01) A61K 9/48 (2006.01) A61K 31/202 (2006.01)

Patent

CA 2221356

Inflammatory bowel disease, especially Crohn's disease and ulcerative colitis, is treated by administration of an oral dosage form, containing as an active principle an omega-3 polyunsaturated acid in free acid form or as a pharmaceutically acceptable salt thereof, which releases the acid in the ileum. Preferably the oral dosage form is a gelatine capsule coated with a poly(ethylacrylate-methyl-methacrylate).

On traite les affections intestinales inflammatoires, notamment la maladie de Crohn et la rectocolite hémorragique, en administrant une forme galénique orale contenant en tant que principe actif un acide oméga-3 polyinsaturé sous forme d'acide libre, ou en tant que sel de cet acide, acceptable sur le plan pharmacologique, le principe actif libérant l'acide dans l'iléon. De préférence, cette forme galénique est contenue dans une gélule de gélatine, laquelle est enrobée d'un poly(éthylacrylate-méthyl-méthacrylate).

Affiliated with

Also associated with

Rating

Treatment of inflammatory bowel disease using oral dosage... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of inflammatory bowel disease using oral dosage..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of inflammatory bowel disease using oral dosage... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1479698